Gene-Environment Interactions Underlying the Effect of Cannabis in First Episode Psychosis

被引:0
作者
Maria Pelayo-Teran, Jose [1 ]
Suarez-Pinilla, Paula [1 ]
Chadi, Nicholas [3 ]
Crespo-Facorro, Benedicto [1 ,2 ]
机构
[1] Univ Cantabria, Dept Psychiat, IFIMAV, Hosp Univ Marques de Valdecilla,Sch Med, Santander 39008, Spain
[2] Ctr Invest Biomed Red Salud Mental, CIBERSAM, Madrid, Spain
[3] McGill Univ, Fac Med, Montreal, PQ H3G 1Y6, Canada
关键词
Schizophrenia; cannabinoids; gene-environment interaction; genetics; CB1; causality; COMT; CATECHOL-O-METHYLTRANSFERASE; SCHIZOPHRENIA-SPECTRUM DISORDERS; HETEROZYGOUS NEUREGULIN-1 MICE; BDNF VAL66MET POLYMORPHISM; NEUROLOGICAL SOFT SIGNS; CENTRAL-NERVOUS-SYSTEM; NEUROTROPHIC FACTOR; HIGH-RISK; DOPAMINE RELEASE; DEVELOPMENTAL EXPRESSION;
D O I
暂无
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cannabis use may be considered as an additional risk factor in a diathesis-stress model of schizophrenia where the risk of developing the illness would be higher in genetic vulnerable people. In this regard, much of the research on cannabis and psychosis is currently focusing on gene-environment interactions. The present review will focus on the interaction between genes and cannabis exposure in the development of psychotic symptoms and schizophrenia and the biological mechanisms of cannabis. Cannabis use has been shown to act together with other environmental factors such as childhood trauma or urbanicity producing synergistic dopamine sensitization effects. Studies on gene-environment interaction have mainly included genetic variants involved in the regulation of the dopaminergic system. The most promising genetic variants in this field are COMT, CNR1, BDNF, AKT1 and NRG1. Additionally, the interaction with other environmental factors and possible gene-gene interactions are considered in the etiological model.
引用
收藏
页码:5024 / 5035
页数:12
相关论文
共 164 条
  • [1] Retrograde endocannabinoid signaling at striatal synapses requires a regulated postsynaptic release step
    Adermark, Louise
    Lovinger, David M.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (51) : 20564 - 20569
  • [2] Twin study of illness history variables in psychosis
    Allan, Charlotte L.
    Cardno, Alastair G.
    Rijsdijk, Fruehling V.
    Kalidindi, Sridevi
    Farmer, Anne
    Murray, Robin M.
    McGuffin, Peter
    [J]. SCHIZOPHRENIA RESEARCH, 2009, 115 (2-3) : 237 - 244
  • [3] Anterograde transport of brain-derived neurotrophic factor and its role in the brain
    Altar, CA
    Cai, N
    Bliven, T
    Juhasz, M
    Conner, JM
    Acheson, AL
    Lindsay, RM
    Wiegand, SJ
    [J]. NATURE, 1997, 389 (6653) : 856 - 860
  • [4] The effects of cannabinoids on the brain
    Ameri, A
    [J]. PROGRESS IN NEUROBIOLOGY, 1999, 58 (04) : 315 - 348
  • [5] CANNABIS AND SCHIZOPHRENIA - A LONGITUDINAL-STUDY OF SWEDISH CONSCRIPTS
    ANDREASSON, S
    ENGSTROM, A
    ALLEBECK, P
    RYDBERG, U
    [J]. LANCET, 1987, 2 (8574) : 1483 - 1486
  • [6] Cannabis-induced psychosis and subsequent schizophrenia-spectrum disorders: follow-up study of 535 incident cases
    Arendt, M
    Rosenberg, R
    Foldager, L
    Perto, G
    Munk-Jorgensen, P
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2005, 187 : 510 - 515
  • [7] Cannabis use in adolescence and risk for adult psychosis: longitudinal prospective study
    Arseneault, L
    Cannon, M
    Poulton, R
    Murray, R
    Caspi, A
    Moffitt, TE
    [J]. BRITISH MEDICAL JOURNAL, 2002, 325 (7374): : 1212 - 1213
  • [8] Causal association between cannabis and psychosis: examination of the evidence
    Arseneault, L
    Cannon, M
    Witton, J
    Murray, RM
    [J]. BRITISH JOURNAL OF PSYCHIATRY, 2004, 184 : 110 - 117
  • [9] Cannabinoids modulate synaptic strength and plasticity at glutamatergic synapses of rat prefrontal cortex pyramidal neurons
    Auclair, N
    Otani, S
    Soubrie, P
    Crepel, F
    [J]. JOURNAL OF NEUROPHYSIOLOGY, 2000, 83 (06) : 3287 - 3293
  • [10] AXELROD J, 1958, J BIOL CHEM, V233, P702